Advertisement

The ASCO Post Editorial Board

Advertisement

 

The Editors' conflict of interest disclosure information is available here.


Associate Editors

    ALLISON BETOF-WARNER, MD, PhD, Stanford University Medical Center

    ALICIA MORGANS, MD, MPH , Dana-Farber Cancer Institute

    OMID HAMID, MD, The Angeles Clinic, an affiliate of Cedars-Sinai

    ANA GLEISNER, MD, University of Colorado Cancer Center

    SUSAN PARSONS, MD, MRP, Tufts University School of Medicine

    ANDREA ZIMMER, MD, University of Nebraska Medical Center

    WILLIAM C. WOOD, MD, Winship Cancer Institute, Emory University

    KAREN M. WINKFIELD, MD, PhD, Wake Forest School of Medicine

    JAMIE H. VON ROENN, MD, American Society of Clinical Oncology

    STEVEN E. VOGL, MD, Bronx, New York

    VAMSI VELCHETI, MD, NYU Langone Health/Perlmutter Cancer Center

    THOMAS J. SMITH, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    SAMUEL SILVER, MD, PhD, University of Michigan Health System

    ANDREW D. SEIDMAN, MD, Memorial Sloan Kettering Cancer Center

    LEE S. SCHWARTZBERG, MD, University of Tennessee Health Science Center

    RICHARD L. SCHILSKY, MD, FACP, FSCT, FASCO, Professor Emeritus, University of Chicago

    MICHAEL A. ROTH, MD, The University of Texas MD Anderson Cancer Center

    STEVEN T. ROSEN, MD, City of Hope National Medical Center

    DEREK RAGHAVAN, MD, PhD, Levine Cancer Institute, Carolinas HealthCare System

    DAVID PFISTER, MD, Memorial Sloan Kettering Cancer Center

    JAMES L. MULSHINE, MD, Rush University Medical Center

    URSULA A. MATULONIS, MD , Dana-Farber Cancer Institute

    RAMI MANOCHAKIAN, MD, Mayo Clinic Florida

    STUART LICHTMAN, MD, FACP, FASCO, Memorial Sloan Kettering Cancer Center–Commack, New York

    ALLEN S. LICHTER, MD, Ann Arbor, Michigan

    BONNIE KY, MD, MSCE, FACC, University of Pennsylvania, Philadelphia

    PAMELA KUNZ, MD, Yale University School of Medicine, Yale Cancer Center

International Editors

    YÜKSEL ÜRÜN, MD, Ankara University, Ankara, Turkey

    DANIEL A. VOROBIOF, MD, Sandton Oncology Centre, Johannesburg, South Africa

    JOHN F. SMYTH, MD, University of Edinburgh, Edinburgh, Scotland

    NAGI EL-SAGHIR, MD, American University of Beirut, Lebanon

    MIRIAM MUTEBI, MD, Aga Khan University, Nairobi, Kenya

    CLARISSA MATHIAS, MD, NOB/Oncoclinicas, Salvador, Brazil

    JACEK JASSEM, MD, Medical University of Gdansk, Poland

    MARY GOSPODAROWICZ, MD, Princess Margaret Hospital, Toronto, Ontario, Canada

    JEFF DUNN, PhD, AO, President, UICC; University of Southern Queensland in Australia,

    VOLKER S. DIEHL, MD, FASCO, German Hodgkin Study Group , Cologne, Germany

    RAKESH CHOPRA, MD, Medical Oncology & Hematology, New Delhi & Gurugram, India

    EDUARDO CAZAP, MD, PhD, International Union Against Cancer (UICC), Buenos Aires, Argentina

 

Advertisement

Advertisement




Advertisement